Academic Journal

Expression, Purification, and Comparative Inhibition of Helicobacter pylori Urease by Regio-Selectively Alkylated Benzimidazole 2-Thione Derivatives.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Expression, Purification, and Comparative Inhibition of Helicobacter pylori Urease by Regio-Selectively Alkylated Benzimidazole 2-Thione Derivatives.
Συγγραφείς: Mohammed SO; Medicinal and Aromatic Plants and Traditional Medicine Research Institute, National Center for Research, Khartoum 11111, Sudan., El Ashry SHE; Chemistry Department, Faculty of Science, Alexandria University, Alexandria 21568, Egypt., Khalid A; Medicinal and Aromatic Plants and Traditional Medicine Research Institute, National Center for Research, Khartoum 11111, Sudan.; Substance Abuse and Toxicology Research Center, Jazan University, Jazan 45142, Saudi Arabia., Amer MR; Chemistry Department, Faculty of Science, Alexandria University, Alexandria 21568, Egypt., Metwaly AM; Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt.; Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt., Eissa IH; Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt., Elkaeed EB; Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah, Riyadh 13713, Saudi Arabia., Elshobaky A; Botany Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt., Hafez EE; Plant Protection and Biomolecular Diagnosis Department, City of Scientific Research and Technological Applications, ARADI, Alexandria 21934, Egypt.
Πηγή: Molecules (Basel, Switzerland) [Molecules] 2022 Jan 27; Vol. 27 (3). Date of Electronic Publication: 2022 Jan 27.
Τύπος έκδοσης: Comparative Study; Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE
Imprint Name(s): Original Publication: Basel, Switzerland : MDPI, c1995-
Ιατρικοί όροι (MeSH): Urease*/antagonists & inhibitors , Urease*/biosynthesis , Urease*/genetics , Urease*/isolation & purification , Molecular Docking Simulation*, Benzimidazoles/*chemistry , Enzyme Inhibitors/*chemistry , Helicobacter pylori/*enzymology, Bacterial Proteins/antagonists & inhibitors ; Bacterial Proteins/biosynthesis ; Bacterial Proteins/genetics ; Bacterial Proteins/isolation & purification ; Helicobacter pylori/genetics
Περίληψη: The urease enzyme has been an important target for the discovery of effective pharmacological and agricultural products. Thirteen regio-selectively alkylated benzimidazole-2-thione derivatives have been designed to carry the essential features of urease inhibitors. The urease enzyme was isolated from Helicobacter pylori as a recombinant urease utilizing the His-tag method. The isolated enzyme was purified and characterized using chromatographic and FPLC techniques showing a maximal activity of 200 mg/mL. Additionally, the commercial Jack bean urease was purchased and included in this study for comparative and mechanistic investigations. The designed compounds were synthesized and screened for their inhibitory activity against the two ureases. Compound 2 inhibited H. pylori and Jack bean ureases with IC50 values of 0.11; and 0.26 mM; respectively. While compound 5 showed IC50 values of 0.01; and 0.29 mM; respectively. Compounds 2 and 5 were docked against Helicobacter pylori urease (PDB ID: 1E9Y; resolution: 3.00 Å) and exhibited correct binding modes with free energy (ΔG) values of -9.74 and -13.82 kcal mol-1; respectively. Further; the in silico ADMET and toxicity properties of 2 and 5 indicated their general safeties and likeness to be used as drugs. Finally, the compounds' safety was authenticated by an in vitro cytotoxicity assay against fibroblast cells.
References: J Biol Inorg Chem. 2000 Feb;5(1):110-8. (PMID: 10766443)
Int J Infect Dis. 2013 Sep;17(9):e723-8. (PMID: 23561799)
Eur J Med Chem. 2014 Apr 9;76:494-505. (PMID: 24602792)
Biochem Biophys Res Commun. 2004 Jul 2;319(3):1053-63. (PMID: 15184088)
Nat Struct Biol. 2001 Jun;8(6):505-9. (PMID: 11373617)
ACS Omega. 2018 Oct 31;3(10):12562-12574. (PMID: 30411010)
J Bacteriol. 1991 Mar;173(6):1920-31. (PMID: 2001995)
Anticancer Drug Des. 1999 Feb;14(1):19-36. (PMID: 10363025)
Crit Rev Microbiol. 1984;11(1):1-12. (PMID: 6373150)
Chem Pharm Bull (Tokyo). 2002 Sep;50(9):1280-2. (PMID: 12237554)
BMC Biochem. 2014 Jul 28;15:15. (PMID: 25065975)
J Chem Theory Comput. 2014 May 13;10(5):1852-1862. (PMID: 24839409)
Toxicol Lett. 1985 Feb-Mar;24(2-3):119-24. (PMID: 3983963)
J Mol Graph Model. 2018 Aug;83:64-73. (PMID: 29775804)
Bioorg Chem. 2021 Oct;115:105206. (PMID: 34339975)
Bioorg Chem. 2020 Dec;105:104380. (PMID: 33128967)
Anal Biochem. 1976 May 7;72:248-54. (PMID: 942051)
Bioorg Med Chem. 2014 Aug 1;22(15):4119-23. (PMID: 24986232)
Mol Microbiol. 2001 Nov;42(4):1021-34. (PMID: 11737644)
Arch Pharm (Weinheim). 2019 Nov;352(11):e1900123. (PMID: 31463953)
Future Med Chem. 2012 Jul;4(11):1495-523. (PMID: 22857536)
Oral Microbiol Immunol. 2000 Oct;15(5):317-24. (PMID: 11154424)
Bioorg Chem. 2021 Feb;107:104532. (PMID: 33334586)
Bioorg Med Chem. 2005 Mar 15;13(6):1931-8. (PMID: 15727849)
J Mol Recognit. 2012 Nov;25(11):549-54. (PMID: 23108614)
Bioorg Chem. 2019 Oct;91:103170. (PMID: 31408830)
Biochem Biophys Res Commun. 2001 Jul 20;285(3):728-33. (PMID: 11453654)
Science. 1995 May 19;268(5213):998-1004. (PMID: 7754395)
Bioorg Med Chem. 2010 Apr 15;18(8):2937-53. (PMID: 20359898)
Biomolecules. 2021 Mar 19;11(3):. (PMID: 33808721)
Bioorg Chem. 2020 Oct;103:104233. (PMID: 32882440)
J Am Chem Soc. 2004 Mar 31;126(12):3714-5. (PMID: 15038715)
J Med Microbiol. 1993 Nov;39(5):338-44. (PMID: 8246250)
Bioorg Med Chem. 2006 Jun 1;14(11):3635-42. (PMID: 16455261)
Eur J Pharm Sci. 2004 Feb;21(2-3):323-9. (PMID: 14757505)
Bioorg Chem. 2021 Sep;114:105105. (PMID: 34175720)
J Enzyme Inhib Med Chem. 2010 Apr;25(2):296-9. (PMID: 20222765)
Biochim Biophys Acta. 1977 Oct 13;484(2):433-42. (PMID: 20965)
Bioorg Med Chem. 2017 Feb 15;25(4):1496-1513. (PMID: 28117121)
Microbiol Mol Biol Rev. 2016 Jun 15;80(3):629-61. (PMID: 27307579)
Molecules. 2021 May 10;26(9):. (PMID: 34068579)
Bioorg Chem. 2007 Jun;35(3):233-42. (PMID: 17169398)
J Med Chem. 2004 Aug 26;47(18):4463-70. (PMID: 15317458)
Mol Divers. 2021 May;25(2):1-13. (PMID: 32095975)
Microbiol Rev. 1995 Sep;59(3):451-80. (PMID: 7565414)
Bioorg Med Chem. 2021 Jan 1;29:115872. (PMID: 33214036)
Grant Information: TUMA-2021-4 Research center at AlMaarefa University for funding this work under TUMA project
Contributed Indexing: Keywords: benzimidazole 2-thione; molecular docking; o-phenylenediamine; recombinant urease; regioselectivity; urease inhibition
Substance Nomenclature: 0 (Bacterial Proteins)
0 (Benzimidazoles)
0 (Enzyme Inhibitors)
EC 3.5.1.5 (Urease)
Entry Date(s): Date Created: 20220215 Date Completed: 20220223 Latest Revision: 20220223
Update Code: 20260130
PubMed Central ID: PMC8838460
DOI: 10.3390/molecules27030865
PMID: 35164122
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1420-3049
DOI:10.3390/molecules27030865